Thursday, July 22, 2021 8:10:04 AM
NEWH looks like it found the bottom range...Taking a starter here...
14C from May 2021...An amendment to our Articles of Incorporation, as amended (the “Articles of Incorporation”) to increase the total number of shares of authorized common stock to 6,000,000,000 shares of common stock from 3,000,000,000.
Chart...https://schrts.co/mwkpgMxT ...
20% of life is what happens to you and 80% is how you react to what happens to you...
Recent NEWH News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 09:30:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 09:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 09:30:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 09:30:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 09:30:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 09:30:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 09:30:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 09:30:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 09:30:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2023 10:00:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 09:30:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 09:30:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 08:30:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2023 08:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 08:05:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 08:05:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2023 08:56:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2023 08:15:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/19/2023 08:30:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/03/2023 08:30:37 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM